Singapore, April 24 -- Singapore-based Esco Lifesciences Group has announced the acquisition of Allwin Medical Devices, Inc., a leading manufacturer of assisted reproductive technology (ART)/ in vitro fertilization (IVF) consumables in the US.
Allwin Medical will continue to operate under its established brand and will become a key pillar within Esco's Medical portfolio, alongside Esco Medical, further strengthening Esco's global position in reproductive medicine.The acquisition reinforces Esco's strategy and commitment to deliver integrated ART/IVF workflow solutions, combining advanced equipment, time lapse imaging, high-quality consumables, digital traceability and witnessing, and AI-enabled embryo assessment and clinical support into...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.